✦ LIBER ✦

Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma

✍ Scribed by Su-Shun Lo; Chew-Wun Wu; Kwan-Hwa Chi; Hsiuo-Shan Tseng; King-Han Shen; Mao-Chih Hsieh; Wing-Yiu Lui

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 95 KB
Volume: 89
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20000701)89:1<29::aid-cncr5>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recent advances in surgical treatment ha

Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma

✍ Eigo Otsuji; Toshiharu Yamaguchi; Kiyoshi Sawai; Akeo Hagiwara; Hiroki Taniguchi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## RESULTS. Postoperative survival was significantly improved in the later groups for patients with Stage I, II, III, and IV disease. A multivariate analysis of prognostic factors revealed that the time period during which the gastrectomy was performed was an independent predictor of survival. ##

The role of secondary cytoreductive surg

The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma

✍ Scott M. Eisenkop; Richard L. Friedman; Nick M. Spirtos 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

BACKGROUND. This study examined the impact of secondary cytoreductive surgery on survival of patients with recurrent epithelial ovarian carcinoma. ## METHODS. One hundred six patients with a disease free interval (DFI) Ͼ 6 months after primary treatment underwent secondary cytoreductive surgery. M

Successful intraperitoneal hyperthermic

Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma

✍ Shigeru Fujimoto; Makoto Takahashi; Takaaki Mutou; Kokuriki Kobayashi; Tadashi T 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

## Background: The majority of advanced gastric carcinoma patients with serosal invasion die of peritoneal recurrence, even when a curative gastrectomy is performed, because peritoneal recurrence occurs due to intraperitoneal free tumor cells that detach from the serosal-invaded focus. in an attemp

The fate and prognostic value of occult

The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence

✍ Wolfgang Janni; Florian Hepp; Dorothea Rjosk; Christina Kentenich; Barbara Strob 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

A phase II study of 5-fluorouracil, leuc

A phase II study of 5-fluorouracil, leucovorin, and interferon-α in the treatment of patients with metastatic or recurrent gastric carcinoma : An Eastern Cooperative Oncology Group study (E5292)

✍ Gary R. Hudes; Stuart Lipsitz; Jean Grem; Mary Morrisey; Louis Weiner; John W. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Chemotherapy has a limited impact on adenocarcinoma of the stomach. Although biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (LV) and interferon-␣ (IFN-␣) has improved the outcomes of patients with metastatic colorectal carcinoma compared with 5-FU alone, this approach has not been ext

A randomized Phase III trial of etoposid

A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma

✍ Fikri İçli; İsmail Çelik; Faruk Aykan; Aytuǧ Üner; Ahmet Demirkazik; Ahmet Özet; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with adv